Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05080621
Title Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC
Indications

gastrointestinal stromal tumor

Therapies

Binimetinib + Ripretinib

Age Groups: senior | adult
Covered Countries


No variant requirements are available.